Topic

Biotech

2 K-Dense articles on Biotech — research automation, benchmarks, and case studies from the K-Dense team.

AI-Powered Biotech Due Diligence: Structure Therapeutics and the $100B GLP-1 Opportunity
K-Dense Web delivers a 7-step due diligence on Structure Therapeutics' GSBR-1290, an oral GLP-1 agonist targeting a $6.5B peak revenue obesity opportunity.
May 6, 202611 min read
Pharma Competitive Intelligence in One Session: CT-388 and the GLP-1/GIP Obesity Landscape
K-Dense Web queried 4 databases and ran 7 Python scripts to produce a 44-page competitive intelligence report on CT-388, Roche's GLP-1/GIP obesity agonist.
April 3, 202611 min read

AI-Powered Biotech Due Diligence: Structure Therapeutics and the $100B GLP-1 Opportunity